When comparing the relationship between the expression of p53 or p53R2 and the clinical response to CRT, CRT was effective in patients who had p53 (−) tumours (P=0.0001) or p53R2 (−) tumours (P=0.0013). The gene discussed is TP53; the disease is neoplasm.